Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients (Fit2ThriveMB)

28 settembre 2026 aggiornato da: Siobhan M Phillips, Northwestern University

The purpose of this study is to examine which of four components of a digital health intervention using an App and Fitbit meaningfully contribute to increased physical activity in Metastatic Breast Cancer Patients.

Participants will be asked to:

  • Wear a Fitbit and use an app, use 0 to 3 other components for 24 weeks and attend 6 or 12 coaching coaching calls in the first 12 weeks to increase daily steps.
  • Complete a questionnaire at baseline, week 12 and week 24
  • Complete functional performance test (FPT) via Zoom at baseline, week 12 and week 24
  • Wear a research activity monitor (Accelerometer) for 7 days at baseline, week 12 and week 24

Panoramica dello studio

Descrizione dettagliata

Multiphase Optimization Strategy (MOST) methodology will be used to determine which intervention components or component combinations optimally increase daily steps in a 12-week intervention with a 12-week follow-up. MOST is a framework adapted from engineering that uses highly efficient factorial experiments to evaluate individual, and combined, effects of intervention components to determine which ones can be reduced, eliminated, or replaced to improve efficiency. Insufficiently active people with metastatic breast cancer (MBC) will receive a core intervention consisting of the FIt2ThriveMB app and Fitbit and be randomly assigned to four components, each with two-levels, under consideration for inclusion in the optimized intervention: 1) EHR-integration (on v. off); 2) coaching dose (weekly v. bi-weekly; 3) social+ (on v. off) and 4) goal-setting type (highly tailored v. static). The effects of increasing PA on symptom burden, other intensity activities (i.e. moderate to vigorous, light and sedentary), and functional performance and potential mediators and moderators of component effects will also be examined. Knowledge gained from this study will inform the development of more effective and scalable interventions to improve health and disease outcomes in this population.

Tipo di studio

Interventistico

Iscrizione (Stimato)

224

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Femmina

Descrizione

Inclusion Criteria:

  • Female sex assigned at birth, age 18 years or older
  • Diagnosed with metastatic breast cancer or locally advanced disease not amenable to surgical resection.
  • Self-report engagement in <150 min/week of moderate to vigorous physical activity
  • Ownership of an Android or iPhone with an up-to-date version of the operating system
  • Internet access to complete assessments
  • Fluency in spoken and written English
  • Willingness to obtain medical clearance to participate.

Exclusion Criteria:

  • Untreated brain metastases
  • Breast cancer with metastases to only the axillary lymph nodes.
  • Self-reported absolute contraindications to exercise (i.e., non-ambulatory, acute myocardial infarction, severe cognitive or functional impairment)
  • Currently pregnant or plans to become pregnant
  • Plans to move out of the United States in next 12 months
  • Current enrollment in another dietary or physical activity trial

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione fattoriale
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: 1- Core, EHR, Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Sperimentale: 2- Core, EHR, Bi-Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Sperimentale: 3- Core, EHR, Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Sperimentale: 4- Core, EHR, Bi-Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Sperimentale: 5- Core, EHR, Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Sperimentale: 6- Core, EHR, Bi-Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Sperimentale: 7- Core, EHR, Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Sperimentale: 8- Core, EHR, Bi-Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Sperimentale: 9- Core, Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Sperimentale: 10- Core, Bi-Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Sperimentale: 11- Core, Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Sperimentale: 12- Core, Bi-Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Sperimentale: 13- Core, Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Sperimentale: 14- Core, Bi-Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Sperimentale: 15- Core, Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Sperimentale: 16- Core, Bi-Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Steps
Lasso di tempo: Baseline, 12 and 24 weeks

The ActiGraph accelerometer will be used. Participants will wear the device during all waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip.

Baseline, 12 and 24 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
ActiGraph measured MVPA
Lasso di tempo: Baseline, 12 and 24 weeks

Moderate to vigorous physical activity will be measured using the ActiGraph. Participants will wear the device during waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip. Freedson cut points will be used to determine this activity as 2,690-9,642 CPM.

Baseline, 12 and 24 weeks
ActiGraph measured light activity
Lasso di tempo: Baseline, 12 and 24 weeks

Light intensity physical activity will be measured using the ActiGraph. I Participants will wear the device during waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip. Freedson cutpoints for light activity are defined as Light: 0 - 2,689 CPM.

Baseline, 12 and 24 weeks
ActiGraph measured sedentary behavior
Lasso di tempo: Baseline, 12 and 24 weeks

Sedentary behavior will be measured using the ActiGraph. Participants will wear the device during waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip. Freedson cutpoints for sedentary behavior are defined as <100 CPM.

Baseline, 12 and 24 weeks
Godin Leisure Time Exercise Questionnaire
Lasso di tempo: Baseline, 12 and 24 weeks

Participants will be asked to indicate frequency of participation in strenuous (e.g., jogging), moderate (e.g., fast walking), and mild (e.g., easy walking) exercise over the past 7 days and average time spent in each activity. Activity frequencies will be multiplied by 9, 5, and 3 metabolic equivalents, respectively, and summed to create a total leisure time activity score. Weekly minutes of total, light, moderate, and vigorous activity will be calculated by multiplying the frequency and time of each activity. This value will be divided by 7 to obtain daily averages.

Baseline, 12 and 24 weeks
Short Physical Performance Battery (SPPB) Total Score
Lasso di tempo: Baseline, 12 weeks, 24 weeks

The SPPB score is based on timed measures of gait speed, ability to rise from a chair, and standing balance. Gait speed will be measured using the better of two recorded times over a 4-meter course. Chair stand time will be measured as the time needed to rise five times from a seated position in a chair, with arms folded across the chest. For the balance test, participants will be asked to maintain their feet side-by-side, semi-tandem, and tandem positions for 10 seconds each. Each individual performance measure will be scored according to established cut points and aggregated for a total SPPB score.

Baseline, 12 weeks, 24 weeks
PROMIS Physical Function
Lasso di tempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure physical function with 4 items over the past 7 days. Items are combined using a t-score metric where higher score is better.

Baseline, 12 and 24 weeks
PROMIS Anxiety
Lasso di tempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Anxiety with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Depression
Lasso di tempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Depression with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Fatigue
Lasso di tempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Fatigue with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Ability to Participate in Social Roles and Activities
Lasso di tempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Ability to Participate in Social Roles and Activities with 4 items over the past 7 days. Items are combined using a t-score metric where the higher score is better.

Baseline, 12 and 24 weeks
PROMIS Sleep Disturbance
Lasso di tempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure sleep disturbance with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Pain Interference
Lasso di tempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure pain interference with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Pain Intensity
Lasso di tempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure pain intensity with 1 item using a scale 1-10 over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 gennaio 2027

Completamento primario (Stimato)

1 gennaio 2031

Completamento dello studio (Stimato)

15 giugno 2031

Date di iscrizione allo studio

Primo inviato

18 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

18 settembre 2026

Primo Inserito (Effettivo)

25 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

1 ottobre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

28 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • STU00224173
  • R01CA305818 (Sovvenzione/contratto NIH degli Stati Uniti)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi